Skip to main content

Advertisement

Figure 3 | Critical Care

Figure 3

From: Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study

Figure 3

Critical illness myopathy and systemic inflammation. Normal (≥3 mV) and abnormal (< 3 mV) direct muscle stimulation compound muscle action potentials (dmCMAP), (a) IL-6 plasma levels, (b) IL-10 plasma levels at median day (25th/75th percentile) 5 (3 to 7) and median day 8 (6 to 10,25). Patients with impaired muscle membrane excitability had significantly higher IL-6 plasma levels but no significant differences of IL-10 plasma levels at both measurement intervals.

Back to article page